Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology

Completed

• Conditions: Deep Venous Thrombosis

• Registration Number: NCT04452422
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Severe SARS-CoV-2 infection, responsible of COVID-19, is accompanied by many venous thromboembolic events. Antithrombotic treatment is the cornerstone of management of many neurovascular diseases (NVDs) and the benefit-risk ratio is crucial to avoid hemorrhagic complications. Therefore, in non-severe COVID-19 patients affected by NVDs, the diagnostic of deep venous thrombosis (DVT) is challenging. Using bedside Doppler ultrasonography (DUS) of lower limbs, this study investigated the rates of DVT in these patients in stroke unit.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-06
• Study Start: 2020-06-23
• Study First Submitted: 2020-06-23
• Study First Submitted QC: 2020-06-29
• Study First Posted: 2020-06-30
• Primary Completion: 2020-09-23
• Study Completion: 2020-09-23
• Last Update Submitted: 2021-10-07
• Last Update Posted: 2021-10-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of cumulated deep venous thrombosis among the hospitalization	Day 7 after admisssion

Trial Locations

Locations (1)

Service Unité Neurovasculaire; 🇫🇷 Strasbourg, France